Difference between revisions of "Part:BBa K3733007:Design"

(→‎References)
(→‎References)
 
Line 20: Line 20:
  
 
===References===
 
===References===
−
Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.
+
Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.

Latest revision as of 12:36, 28 September 2021


LTA: A novel antimicrobial peptide


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Codon optimization is conducted base on Escherichia coli codon bias.



Source

The original sequence of LTA is determined by Zhang, Lulu, et al. (2019)

Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.


References

Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.